Researcher Spotlight
Ravi Majeti, MD, PhD
Stanford School of Medicine
Transforming the Detection of Minimal Residual Disease (MRD) with Single-cell DNA Analysis
Dr. Ravi Majeti shares his thoughts on using the Tapestri™ Platform to measure residual disease in acute myeloid leukemia (AML).
SHARE THIS PAGE
Researcher Spotlight
Customer Spotlight: Servier Pharmaceuticals
Researcher Spotlight
Two mutations in RNA splicing factors from the same cell confirmed with single-cell DNA-Seq
Justin Taylor, MD
University of Miami
Researcher Spotlight
Enhance the clinical evaluation of AML MRD by uncovering clonality
Asiri Ediriwickrema, MD
Stanford University
Researcher Spotlight
Using CRISPR to understand different combinations of gene alterations
John Lee, MD, PhD
Fred Hutch